Jennifer Humes
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Jennifer Humes currently works at Roivant Sciences Ltd., as Chief Accounting Officer from 2025 and Roivant Sciences, Inc., as Chief Accounting Officer from 2025.
Ms. Humes also formerly worked at JPMorgan Chase & Co., as Controller-Global Investment Banking in 2024.
Ms. Humes received her undergraduate degree from the University of St. Thomas.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ROIVANT SCIENCES LTD. 0,02 % | 20/04/2026 | 113 364 ( 0,02 % ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ROIVANT SCIENCES LTD. | Comptroller/Controller/Auditor | 20/02/2025 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Comptroller/Controller/Auditor | 20/02/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01/12/2024 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
JPMorgan Chase & Co.
JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
University of St. Thomas
University of St. Thomas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national